Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
18 March 2019Website:
http://www.cyclerion.comNext earnings report:
13 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 23:26:30 GMTDividend
Analysts recommendations
Institutional Ownership
CYCN Latest News
CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced that Regina Graul, Ph.D.
What type of business is Cyclerion Therapeutics?
Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
What sector is Cyclerion Therapeutics in?
Cyclerion Therapeutics is in the Healthcare sector
What industry is Cyclerion Therapeutics in?
Cyclerion Therapeutics is in the Biotechnology industry
What country is Cyclerion Therapeutics from?
Cyclerion Therapeutics is headquartered in United States
When did Cyclerion Therapeutics go public?
Cyclerion Therapeutics initial public offering (IPO) was on 18 March 2019
What is Cyclerion Therapeutics website?
https://www.cyclerion.com
Is Cyclerion Therapeutics in the S&P 500?
No, Cyclerion Therapeutics is not included in the S&P 500 index
Is Cyclerion Therapeutics in the NASDAQ 100?
No, Cyclerion Therapeutics is not included in the NASDAQ 100 index
Is Cyclerion Therapeutics in the Dow Jones?
No, Cyclerion Therapeutics is not included in the Dow Jones index
When was Cyclerion Therapeutics the previous earnings report?
No data
When does Cyclerion Therapeutics earnings report?
The next expected earnings date for Cyclerion Therapeutics is 13 November 2024